Informations: Ceci n’est pas la version la plus récente du modèle de données. Vous trouverez un aperçu de la version à gauche, sous Versions. Vous trouverez la version la plus actuelle ici.
Informations:
Erreur:
ID
22041
Description
Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00327652
Lien
https://clinicaltrials.gov/show/NCT00327652
Mots-clés
Versions (3)
- 16/05/2017 16/05/2017 -
- 16/05/2017 16/05/2017 -
- 20/09/2021 20/09/2021 -
Téléchargé le
16 mai 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Neoplasm Metastasis NCT00327652
Eligibility Neoplasm Metastasis NCT00327652
- StudyEvent: Eligibility
Similar models
Eligibility Neoplasm Metastasis NCT00327652
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
ID.1
Item
1. documented carcinoma refractory to standard treatment (or for whom no standard treatment is available). hepatocellular carcinoma (hcc) is not allowed.
boolean
ID.2
Item
2. hepatic metastases
boolean
ECOG performance status | Karnofsky Performance Status
Item
3. ecog performance status of 0 or 1, or karnofsky performance status (kps) of 80% to 100%.
boolean
C1520224 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
C0206065 (UMLS CUI [2])
ID.4
Item
4. adequate organ function as defined by clinical hematology and chemistry assays.
boolean
Exclusion Criteria
Item
exclusion criteria (abbreviated):
boolean
C0680251 (UMLS CUI [1])
ID.6
Item
1. known central nervous system metastases.
boolean
ID.7
Item
2. history of allergic reactions attributed to sulfa or beta-lactam antibiotics.
boolean
ID.8
Item
3. cardiac conditions associated with high- or moderate-risk of endocarditis.
boolean
ID.9
Item
4. intra-arterial hepatic catheter, hepatic cirrhosis, or clinically relevant ascites.
boolean
ID.10
Item
5. artificial (prosthetic) joint or other artificial implant or devices that cannot easily be removed.
boolean
ID.11
Item
6. known coagulation disorder or recent thromboembolic event.
boolean
ID.12
Item
7. use of immunosuppressive agent, chemotherapy, or radiation therapy within 28 days prior to crs-100; bone marrow or stem cell transplant or a major organ allograft; autoimmune disease.
boolean
ID.13
Item
8. current history of gallstones or kidney stones.
boolean
ID.14
Item
9. infection with hiv, human t-lymphotropic virus type 1 (htlv-1), hepatitis c virus (hcv), or hepatitis b virus (hbv).
boolean
Pregnancy | Breast Feeding
Item
10. pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])